Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)
|
September 28, 1998
Changing presentation and management of neutropenic enterocolitis
H K Song, D Kreisel, R Canter, et al.
Bone Marrow Transplantation
|
October 30, 2012
Trimming the fat: obesity and hematopoietic cell transplantation
B M Weiss, D T Vogl, N A Berger, et al.
Journal of Clinical Neuro-Ophthalmology
|
March 1, 1991
Reactive lymphohistiocytosis with recurrence in the optic chiasm
S L Galetta, E A Stadtmauer, D G Hicks, et al.
Diagnostic Cytopathology
|
April 16, 1999
Cerebral spinal fluid involvement by Hodgkin's disease diagnosed by CSF cytology and immunocytochemistry
L A Perez-Jaffe, K E Salhany, R J Green, et al.
British Journal of Haematology
|
April 1, 1991
Danazol treatment of myelodysplastic syndromes
E A Stadtmauer, P A Cassileth, M Edelstein, et al.
Bone Marrow Transplantation
|
August 1, 1996
4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement
J M Bird, S Luger, P Mangan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol
C R Nichols, J Andersen, H M Lazarus, et al.
Annals of Internal Medicine
|
January 15, 1994
Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG)
J M Rowe, N Ciobanu, J Ascensao, et al.
Clinical Lymphoma
|
November 15, 2001
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy
D E Tsai, S J Schuster, A Matthies, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 7, 2000
Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor
D P Schenkein, Y Koc, T Alcindor, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Archives of Surgery (Chicago, Ill. : 1960)
|
September 28, 1998
Changing presentation and management of neutropenic enterocolitis
H K Song, D Kreisel, R Canter, et al.
Bone Marrow Transplantation
|
October 30, 2012
Trimming the fat: obesity and hematopoietic cell transplantation
B M Weiss, D T Vogl, N A Berger, et al.
Journal of Clinical Neuro-Ophthalmology
|
March 1, 1991
Reactive lymphohistiocytosis with recurrence in the optic chiasm
S L Galetta, E A Stadtmauer, D G Hicks, et al.
Diagnostic Cytopathology
|
April 16, 1999
Cerebral spinal fluid involvement by Hodgkin's disease diagnosed by CSF cytology and immunocytochemistry
L A Perez-Jaffe, K E Salhany, R J Green, et al.
British Journal of Haematology
|
April 1, 1991
Danazol treatment of myelodysplastic syndromes
E A Stadtmauer, P A Cassileth, M Edelstein, et al.
Bone Marrow Transplantation
|
August 1, 1996
4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement
J M Bird, S Luger, P Mangan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol
C R Nichols, J Andersen, H M Lazarus, et al.
Annals of Internal Medicine
|
January 15, 1994
Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG)
J M Rowe, N Ciobanu, J Ascensao, et al.
Clinical Lymphoma
|
November 15, 2001
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy
D E Tsai, S J Schuster, A Matthies, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 7, 2000
Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor
D P Schenkein, Y Koc, T Alcindor, et al.
Page
of 6